Company: BIAF
Filing Date: 2025-09-30
Form Type: 424B4
Source: 0001493152-25-016338
Chunk: 6

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-09-30
Form: 424B4
Chunk 6
---
 payable by us. The offering consisted of 990 shares of our newly designated Series B Convertible Preferred Stock, with a par value $0.001 per share and stated value of $1,000 per share initially convertible into 143,476 shares of our Common Stock at an initial conversion price of $6.90 per share and (ii) warrants to purchase up to 223,824 shares of our Common Stock at an exercise price of $10.52 per share of Common Stock (the “August 2025 Warrants”).

| 3 |

On August 14, 2025, we also completed a warrant inducement transaction with the holder of a warrant, pursuant to which such holder exercised for cash a total of 36,666 warrants originally issued in August 2024 and October 2024, at the reduced exercise price of $6.90 per share, for aggregate gross proceeds of approximately $253,000. In connection with the immediate exercise of the August 2024 and October 2024 Warrants, we issued unregistered common warrants to purchase an aggregate of up to 36,666 shares of Common Stock at an exercise price of $10.52 per share, which warrants are not exercisable until our stockholder approve such exercise.

On September 2, 2025, we entered into
agreements with the holders of our August 2025 Warrants and the warrants issued in our May 2025 public offering (the “May 2025
Warrants”) pursuant to which the Floor Price (as such term is defined in each of the August 2025 Warrants and the May 2025 Warrants)
was increased, effective as of August 12, 2025, from $3.00 to $4.50 per share.

On September 17, 2025, we filed with
the Secretary of State of the State of Delaware a certificate of amendment to our certificate of incorporation to effect a one-for-thirty
(1-for-30) reverse split of our issued and outstanding shares of Common Stock. The Reverse Stock Split became effective as of 4:01 p.m.
Eastern Time on September 18, 2025, and our Common Stock began trading on a split-adjusted basis when Nasdaq opened on September 19,
2025. All share and per share information in this prospectus (other than in the historical financial statements incorporated herein by
reference) has been adjusted to reflect the reverse stock split.

Corporate Information

We were incorporated